Why healthcare funding products succeed or fail on product architecture
A benefit table is not a product. The funders who win design pricing, benefits, networks, claims behaviour and distribution as one architecture — and the ones who struggle assemble them as separate parts.
Most healthcare funding products are not designed. They are assembled. A pricing team sets a contribution, a benefits team builds an option table, a networks team signs provider agreements, and a distribution team takes whatever results to market. Each part is competent on its own terms. The product still underperforms, because the parts were never designed to work as one system.
This is the single most common pattern we see across medical schemes and health insurers, and it is the reason two funders can offer near-identical benefits at similar prices and post very different results. The difference is rarely a single decision. It is architecture: whether the components of the product reinforce one another or quietly work against each other.
What "product architecture" actually means
Product architecture is the set of relationships between the moving parts of a funding product — not the parts themselves. It asks how pricing relates to benefit richness, how benefit design shapes claims behaviour, how the network shapes cost and access, how managed care changes utilisation, and how distribution selects the risk pool that everything else depends on.
When those relationships are designed deliberately, the product has internal logic. A day-to-day benefit is structured to steer members toward the network that the pricing assumes. A chronic benefit is built around the managed care programme that is meant to control its cost. The distribution channel is chosen because it attracts the risk profile the contribution was priced for. Every element carries its weight and supports the next.
When the relationships are left to chance, the product has internal contradictions. The pricing assumes network utilisation the benefit design does not encourage. The chronic benefit is generous but the managed care programme that should contain it is optional. The channel that sells the most volume brings in exactly the members the price cannot sustain. None of these is visible in the benefit table. All of them show up in the claims.
Where products break
Three failure points recur often enough to be worth naming.
The pricing–behaviour gap. Pricing is built on an assumed pattern of member behaviour — where they seek care, how often, and through which providers. Benefit design is what actually shapes that behaviour. When the two are set separately, the assumptions and the incentives diverge. The product is priced for one world and sold into another.
The benefit–network disconnect. A network only creates value if the product routes members through it. If the benefit design does not meaningfully reward network use, the network discount exists on paper but not in the claims. Funders end up paying for network infrastructure they are not using.
The distribution–risk mismatch. Distribution is not a downstream activity. It is a risk-selection mechanism. The channel, the incentive structure and the target segment together determine who joins. A product can be well priced and well designed and still fail because its distribution consistently attracts a risk pool it was never built to carry.
Designing as one system
The alternative is not more analysis in each silo. It is designing the connections deliberately, in sequence, with each decision tested against the next.
Start with the market segment and the risk pool you intend to build, because everything downstream depends on who joins. Define the product option and its position in the portfolio, so it complements rather than cannibalises the options around it. Design the benefits and the network together, so that the benefit structure actively routes members through the network the pricing relies on. Integrate managed care where the cost concentration justifies it, rather than bolting it on afterwards. Then let distribution follow from the segment you set out to reach, not the other way around.
Actuarial work runs through all of it rather than sitting at the end. Pricing logic, claims-ratio analysis and benefit-to-cost modelling are inputs to design decisions, not a compliance check performed once the product is built. The point is not to price a finished product. It is to test the architecture while it can still be changed.
Refresh and turnaround
Most funders are not launching from a blank page. They are carrying a portfolio that grew by accretion — options added over years to answer competitive pressure, each sensible in isolation, none designed against the others. The result is overlap, internal competition and cost that adds no member value.
Turnaround work is architecture applied in reverse. It maps the existing portfolio, finds where options compete with each other, identifies the benefits that carry cost without value, and rebuilds the relationships so the range works as a hierarchy rather than a collection. The hard part is rarely the analysis. It is the discipline to remove and consolidate rather than only add.
The executive question
For a board, the useful question is not "are our benefits competitive?" or "is our pricing right?" Those questions treat the parts in isolation, which is how the problem started. The better question is whether the product is designed as one system — whether pricing, benefits, network, managed care and distribution are pulling in the same direction, and whether anyone can demonstrate that they are.
Products succeed or fail on the strength of their design. The funders that treat product development as architecture, not assembly, are the ones whose numbers hold up when the claims arrive.
Vantage Strategy Advisory
Consultants · Actuarial Advisory · Strategy
From claims reporting to decision intelligence: what healthcare funders need next
Most funders already have more reports than they can use. The gap is not data — it is the distance between a dashboard and a decision. Closing it is a design problem, not a technology one.
Provider networks as an affordability strategy, not only an access rule
Too many networks are designed to control where members go rather than what a product can afford. Treated as an affordability lever, a network becomes one of the most powerful tools a funder has.
Behavioural economics in managed care: moving members from awareness to action
Most managed care and wellness programmes are well designed clinically and weak behaviourally. The gap between knowing and doing is where the value leaks — and it is a design problem with known tools.